Search clinical trials for: GPI-0100

Total 4792 results

British Columbia Cancer Agency

Completed

Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) (Anterior EPI)

Breast Cancer

Canada
Universidad Francisco de Vitoria

Completed

Effects of GPR on Stress and Sleep Quality in Health Sciences (GPRstress)

Stress, Psychological

Spain
University Hospital, Bordeaux

Completed

SPONGIT: Comparison of Two Surgical Approaches in the Treatment of Degenerative Spondylolysthesis (SPONGIT)

Degenerative Spondylolisthesis

France
University of North Carolina, Chapel Hill
Womack Army Medical Center

Recruiting

Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury

Osteoarthritis, Knee | Post-traumatic Osteoarthritis | Anterior Cruciate Ligament Injuries | Quadriceps Muscle Atrophy

United States
Beijing Tiantan Hospital
Peking University People's Hospital; Peking Union Medical College Hospital; Chinese... and other collaborators

Recruiting

Deep Brain Stimulation for Idiopathic Craniofacial Dystonia: GPi or STN (MEIGES)

Deep Brain Stimulation | Craniofacial Dystonia

China
University Hospital Inselspital, Berne
Boston Scientific Corporation

Terminated

Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM (LATESTIM)

Parkinson Disease | Movement Disorders | Neurodegenerative Disorders | Central Nervous System Disease | Basal Ganglia Disease

Switzerland
National Hepatology & Tropical Medicine Research...

Recruiting

Role of Octreotide in Non Variceal Bleeding

Non-variceal Gastrointestinal Bleeding

Egypt
Umeå University
Glaukos Corporation

Completed

Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus

Eye Diseases | Keratoconus | Corneal Disease | Corneal Crosslinking | Corneal Biomechanics | Corneal Densitometry | Scheimpflug Photography

Sweden
Rhode Island Hospital
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) (MATICCE)

Alcohol-Related Disorders | Opioid-Related Disorders
Maastricht University Medical Center

Completed

Effects the Glycemic Index on Metabolic Risk Markers

Metabolic Syndrome X

Netherlands
Fusion Pharmaceuticals Inc.

Recruiting

Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). (TATCIST)

Metastatic Castration Resistant Prostate Cancer

United States
SecuraBio

Completed

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

Hematologic Malignancy

United States, Italy
Charite University, Berlin, Germany
German Alzheimer Society

Completed

Validation and Optimization of the Individual Benefits of Locating Systems in Dementia Care (VODINO)

Dementia

Germany
The Cleveland Clinic

Completed

Hypotension Prediction Index for Blood Pressure Management (HPI)

Intraoperative Hypotension

United States
Mayo Clinic

Completed

Developing and Implementing Asthma-Guidance and Prediction System (a-GPS) for Better Asthma Management

Asthma

United States
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Non-small-cell Lung Cancer

China
University Paris 7 - Denis Diderot

Completed

Influence of a Brief Intervention on CRC Screening (Hem-FMG)

Colorectal Cancer

France
Affinium Pharmaceuticals, Ltd

Completed

A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci

Cellulitis | Wound Infection | Skin and Subcutaneous Tissue Bacterial Infections | Cutaneous Abscess | Burn Infection

United States, Canada
Kamada, Ltd.

Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency (Kamada API)

Alpha 1-Antitrypsin Deficiency

United States
Regeneron Pharmaceuticals
Sanofi

Terminated

REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer

Non-small Cell Lung Cancer

United States, Italy, Lithuania
M.D. Anderson Cancer Center

Recruiting

A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity

Neurotoxicity

United States
Centre Hospitalier Régional d'Orléans

Recruiting

Amyloidosis TTR Flow Reserve Evaluation (AMYTRE)

Amyloid Cardiomyopathy

France
Southern California University of Health Sciences
Sun Ten Pharmaceutical Co Ltd.

Completed

Effects of Lagenbone on Bone Mineral Density

Osteoporosis

United States
Nutrasource Pharmaceutical and Nutraceutical Services...
Ganeden Biotech, Inc.

Completed

Influence of GanedenBC30 (Bacillus Coagulans GBI-30, 6086) on the Gut Microbiome in Healthy Adults

Healthy Volunteers

Canada
University Hospital Plymouth NHS Trust

Completed

Cardiac GSI Feasibility Study

High Risk of Significant Coronary Artery Disease

United Kingdom
M.D. Anderson Cancer Center
Infinity Pharmaceuticals, Inc.

Withdrawn

IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Leukemia
AdvanceCor GmbH
Procorde GmbH

Completed

Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion (PR-15/01)

Myocardial Infarction | Stroke | Thrombosis | Acute Coronary Syndrome

Germany
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy Participants

Healthy

United States
AstraZeneca
Parexel

Terminated

Evaluation of AZD8154 Concentrations in Blood

Asthma

Germany
Betta Pharmaceuticals Co., Ltd.

Unknown

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer

China
Assistance Publique - Hôpitaux de Paris
Laboratoire Crinex

Completed

VITamine D Supplementation in RenAL Transplant Recipients - VITALE (VITALE)

Renal Transplant Candidate for Right Kidney

France
Fusion Pharmaceuticals Inc.

Recruiting

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) (AlphaBreak)

Metastatic Castration-resistant Prostate Cancer

United States
Universidad Francisco de Vitoria

Not yet recruiting

Diaphragmatic Breathing and Global Postural Reeducation on Stress and Sleep Quality in University Students (RPGBREATH23)

Stress | Sleep Disturbance
Wang Shalong
Central South University

Completed

ChatGPT Helping Advance Training for Medical Students: A Study on Self-Directed Learning Enhancement (CHAT-MS)

Medical Education | Artificial Intelligence | Self-Directed Learning

China
Betta Pharmaceuticals Co., Ltd.

Completed

Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors

Solid Tumors

China
Minia University

Completed

Preoperative PPI in Sleeve Gastrectomy

Morbid Obesity

Egypt
MedImmune LLC

Withdrawn

A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer

Breast Cancer

United States
Diabeteszentrum Bad Lauterberg im Harz

Completed

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Type 2 Diabetes
GE Healthcare
Pharmaceutical Product Development, LLC

Completed

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Coronary Artery Disease (CAD)

United States, Germany, Switzerland, Canada, Netherlands, France, Finland
Centre Hospitalier Universitaire Dijon

Completed

the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections. (UTOPIE)

Community Infections

France
Vyaire Medical

Not yet recruiting

Post Market, Prospective Multicenter Observational Study of the Safety and Performance of Bellavista Ventilator

Ventilation Therapy; Complications
Novo Nordisk A/S

Completed

A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

United Kingdom, Romania, Poland, Denmark, Czech Republic, Hungary
GL Pharm Tech Corporation

Completed

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)

Healthy

Korea, Republic of
Novo Nordisk A/S

Completed

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Healthy Volunteers (Diabetes Mellitus, Type 2)

Germany, Denmark
University Hospital, Grenoble

Completed

Interest of Ultrasound Coupled to a Guidance System (GPS) for Central Venous Catheters (CVC) Insertion. (VVC and GPS)

Surgery

France
Quark Pharmaceuticals

Completed

Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

Optic Atrophy | Non-arteritic Anterior Ischemic Optic Neuropathy

United States, Israel
Horizon Therapeutics, LLC

Completed

Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)

Urea Cycle Disorder

United States, Spain, Italy, Switzerland
Exeltis Turkey
Monitor CRO

Active, not recruiting

Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule

Bioavailability

Turkey
GlaxoSmithKline

Completed

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

Pulmonary Disease, Chronic Obstructive

Germany
University of South Florida
Edison Pharmaceuticals Inc

Completed

A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease

Parkinson's Disease

United States

Search clinical trials for: GPI-0100

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations